Skip to main content
Fig. 4 | Stem Cell Research & Therapy

Fig. 4

From: Umbilical cord blood-derived CD11c+ dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy

Fig. 4

In vitro cytotoxic T lymphocyte (CTL) assay. a CTL assay data from three experiments depicting the killing efficacy of the target MCF-7 cells by CTLs generated by pulsed umbilical cord blood (UCB)/periperal blood (PBL)-dendritic cells (DCs). b Percent killing in the irrelevant target cell line H1229. Negligible killing effect was seen in these sets by pulsed UCB/PBL-DCs. Data shown are mean ± SD, n = 3

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512